Company Profile Main Article

Company Profile

Daiichi Sankyo, Inc. is the U.S. headquarters of Tokyo-based Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group, which spans 20 countries. Established in 2006 from the merger of the Daiichi and Sankyo pharmaceutical companies, Daiichi Sankyo, Inc. currently markets therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome and metastatic melanoma.

Company Profile Address

FY 2015 U.S. Sales

$1,540 million

U.S. Employees

Approximately 1,400

Global Employees

Approximately 16,000

U.S. Headquarters

Daiichi Sankyo, Inc.
Two Hilton Court
Parsippany, NJ 07054
Phone: 973-944-2600

Parent Company

Daiichi Sankyo Co., LTD. (TSE 4568)
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo
103-8426, Japan
Phone: +81-3-6225-1111

European Headquarters

Daiichi Sankyo Eurpoe, GhbH
Zielstattstrasse 48
81379 Munich, Germany
Phone: +49-89-7808-0

Global Clinical Development

Daiichi Sankyo Pharma Development
399 Thornall Street
Edison, NJ 08837
Phone: 732-590-5000

Company Profile More Stories

Learn More

Values and MIssion

Daiichi Sankyo company values are the guiding principles that direct our decision-making and the performance of our daily work.

read more ...